Why Tina ?
Rethinking your retina to see better, for longer.
Your retina is remarkable. It converts light that enters the eye into electrical signals your optic nerve sends to your brain, which creates the images you see. As you age, your retina ages with you. But that doesn’t mean vision loss is inevitable.
The Problem
Genetic testing alone Isn’t sufficient.
If your doctor suspects you’re at risk of developing AMD, often due to a family history, they might recommend genetic testing. Your genes, though, are static and only provide one part of the picture. The concentration of Omega-3 in your retina is a key factor for optimal functioning, and it can be influenced by your nutrition and lifestyle.
Our Findings
Your retina can tell you more than your genes alone.
Our studies have shown that a retina affected by AMD contains significantly lower levels of Omega-3 compared to a healthy retina.
Our research is the first to identify a reliable blood biomarker that can predict Omega-3 levels in the retina, with the highest level of precision in scientific literature. Further studies have suggested that a high dietary intake of Omega-3 can reduce your risk of developing AMD, even if you have a genetic predisposition.
Our novel findings were published in the leading medical journals.
Our research is the first to identify a reliable blood biomarker that can predict Omega-3 levels in the retina, with the highest level of precision in scientific literature. Further studies have suggested that a high dietary intake of Omega-3 can reduce your risk of developing AMD, even if you have a genetic predisposition.
Our novel findings were published in the leading medical journals.
Our Unique Tests
Act on Your Retinal Health
We use the most advanced and reliable blood biomarker in the world to help you increase the concentration of Omega-3 in your retina. By using this data to modify your nutrition and lifestyle, you can maintain optimal levels of Omega-3 and reduce your risk for AMD.
Our Research
At the frontier of preventive ocular medicine.
Our research combines the latest technologies, artificial intelligence, and collaboration with a world-leading consortia of scientists, to move beyond a ‘reactive’ approach to retinal diseases like AMD, to a personalized, preventive approach.